# A Comparative Study of LY900014 With Insulin Lispro (Humalog) in Participants With Type 1 Diabetes Mellitus

> **NCT03341299** · PHASE1 · COMPLETED · sponsor: **Eli Lilly and Company** · enrollment: 36 (actual)

## Conditions studied

- Diabetes Mellitus, Type 1

## Interventions

- **BIOLOGICAL:** LY900014
- **BIOLOGICAL:** Insulin Lispro

## Key facts

- **NCT ID:** NCT03341299
- **Lead sponsor:** Eli Lilly and Company
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-11-13
- **Primary completion:** 2018-04-03
- **Final completion:** 2018-04-03
- **Target enrollment:** 36 (ACTUAL)
- **Last updated:** 2020-05-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03341299

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03341299, "A Comparative Study of LY900014 With Insulin Lispro (Humalog) in Participants With Type 1 Diabetes Mellitus". Retrieved via AI Analytics 2026-09-24 from https://api.ai-analytics.org/clinical/NCT03341299. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*